{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:35:05Z","timestamp":1790782505500,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG 19-140-31"],"award-info":[{"award-number":["IRG 19-140-31"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA266579"],"award-info":[{"award-number":["R01 CA266579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.gendis.2023.01.026","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T13:26:49Z","timestamp":1679664409000},"page":"321-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Md Rakibul","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mizanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"Andaloussi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2023.01.026_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41467-017-01433-3","article-title":"Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche","volume":"8","author":"Plebanek","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2023.01.026_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-017-02406-2","article-title":"Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis","volume":"9","author":"Kimura","year":"2018","journal-title":"Nat Commun"},{"issue":"35","key":"10.1016\/j.gendis.2023.01.026_bib6","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"issue":"7718","key":"10.1016\/j.gendis.2023.01.026_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2023.01.026_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-019-1074-3","article-title":"The role of exosomal PD-L1 in tumor progression and immunotherapy","volume":"18","author":"Xie","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.gendis.2023.01.026_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"13","key":"10.1016\/j.gendis.2023.01.026_bib10","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.gendis.2023.01.026_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PD-L1\/2 pathway from discovery to clinical implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1272\/jnms.JNMS.2019_86-2","article-title":"Development of cancer immunotherapy targeting the PD-1 pathway","volume":"86","author":"Kamimura","year":"2019","journal-title":"J Nippon Med Sch"},{"issue":"230","key":"10.1016\/j.gendis.2023.01.026_bib13","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci Signal"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692237","article-title":"Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1\/PD-L1 pathway","volume":"39","author":"Zhang","year":"2017","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrc3105","article-title":"Calcium in tumour metastasis: new roles for known actors","volume":"11","author":"Prevarskaya","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.gendis.2023.01.026_bib16","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.bbamem.2015.06.009","article-title":"Plasma membrane calcium channels in cancer: alterations and consequences for cell proliferation and migration","volume":"1848","author":"D\u00e9liot","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 24","key":"10.1016\/j.gendis.2023.01.026_bib17","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bpj.2017.05.032","article-title":"Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis","volume":"113","author":"Jackson","year":"2017","journal-title":"Biophys J"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/onc.2013.560","article-title":"Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes","volume":"34","author":"Webber","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ncb2000","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"Pt 12","key":"10.1016\/j.gendis.2023.01.026_bib22","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1242\/jcs.115.12.2505","article-title":"The exosome pathway in K562 cells is regulated by Rab11","volume":"115","author":"Savina","year":"2002","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0854.2004.00257.x","article-title":"Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner","volume":"6","author":"Savina","year":"2005","journal-title":"Traffic"},{"issue":"3\u20134","key":"10.1016\/j.gendis.2023.01.026_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jcb.29871","article-title":"RAB5A is associated with genes involved in exosome secretion: integration of bioinformatics analysis and experimental validation","volume":"122","author":"Gorji-Bahri","year":"2021","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.gendis.2023.01.026_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12951-020-00739-7","article-title":"Improvement of stem cell-derived exosome release efficiency by surface-modified nanoparticles","volume":"18","author":"Park","year":"2020","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200911018","article-title":"Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C","volume":"189","author":"Hsu","year":"2010","journal-title":"J Cell Biol"},{"issue":"7","key":"10.1016\/j.gendis.2023.01.026_bib27","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1074\/jbc.M115.705871","article-title":"Munc13-4 is a Rab11-binding protein that regulates Rab11-positive vesicle trafficking and docking at the plasma membrane","volume":"291","author":"Johnson","year":"2016","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib28","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1083\/jcb.201710132","article-title":"A Ca2+-stimulated exosome release pathway in cancer cells is regulated by Munc13-4","volume":"217","author":"Messenger","year":"2018","journal-title":"J Cell Biol"},{"issue":"22","key":"10.1016\/j.gendis.2023.01.026_bib29","doi-asserted-by":"crossref","first-page":"20083","DOI":"10.1074\/jbc.M301642200","article-title":"Exosome release is regulated by a calcium-dependent mechanism in K562 cells","volume":"278","author":"Ariel","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2023.01.026_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fgene.2016.00056","article-title":"Exosomes: the link between GPCR activation and metastatic potential?","volume":"7","author":"Isola","year":"2016","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","article-title":"Exosomes in tumor microenvironment influence cancer progression and metastasis","volume":"91","author":"Kahlert","year":"2013","journal-title":"J Mol Med"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib32","first-page":"457","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gendis.2023.01.026_bib33","doi-asserted-by":"crossref","first-page":"13297","DOI":"10.1038\/ncomms13297","article-title":"L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling","volume":"7","author":"Jacquemet","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016766","article-title":"Molecular mechanisms of the membrane sculpting ESCRT pathway","volume":"5","author":"Henne","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"10.1016\/j.gendis.2023.01.026_bib36","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1002\/pmic.200400876","article-title":"Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry","volume":"4","author":"Mears","year":"2004","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib39","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/0008-5472.CAN-09-2470","article-title":"Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation","volume":"70","author":"Nazarenko","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.gendis.2023.01.026_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-020-03703-z","article-title":"Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake","volume":"467","author":"Jadli","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv Pharmaceut Bull"},{"key":"10.1016\/j.gendis.2023.01.026_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00515-y","article-title":"Potential roles and prognostic significance of exosomes in cancer drug resistance","volume":"11","author":"Mostafazadeh","year":"2021","journal-title":"Cell Biosci"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gendis.2023.01.026_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-019-0739-0","article-title":"Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression","volume":"12","author":"Wu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.gendis.2023.01.026_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.gendis.2023.01.026_bib47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.biopha.2018.03.148","article-title":"Tumor-derived extracellular vesicles in angiogenesis","volume":"102","author":"Song","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gendis.2023.01.026_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","article-title":"Effects of exosomes on pre-metastatic niche formation in tumors","volume":"18","author":"Guo","year":"2019","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12855","article-title":"Extracellular vesicles and oncogenic signaling","volume":"15","author":"Schubert","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gendis.2023.01.026_bib50","doi-asserted-by":"crossref","first-page":"14749","DOI":"10.1038\/s41598-020-71573-y","article-title":"Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as mediators of immune regulation and immunotherapy in cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib52","first-page":"3747","article-title":"Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions","volume":"30","author":"Wada","year":"2010","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib53","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.4049\/jimmunol.179.8.5523","article-title":"The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands","volume":"179","author":"Elsner","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001698","article-title":"Mechanisms underlying low-clinical responses to PD-1\/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1","volume":"9","author":"Yin","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2023.01.026_bib57","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2020.00604","article-title":"The biogenesis, biology, and clinical significance of exosomal PD-L1 in cancer","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib58","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","article-title":"Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.celrep.2018.06.066","article-title":"ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation","volume":"24","author":"Monypenny","year":"2018","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib60","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","article-title":"The importance of exosomal PDL1 in tumour immune evasion","volume":"20","author":"Daassi","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"57","key":"10.1016\/j.gendis.2023.01.026_bib63","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1:predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2023.01.026_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-18132-0","article-title":"IFN\u03b3 induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma","volume":"7","author":"Moon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2023.01.026_bib65","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fonc.2018.00386","article-title":"Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion","volume":"8","author":"Dong","year":"2018","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib67","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/ijc.29519","article-title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer","volume":"138","author":"Balamurugan","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gendis.2023.01.026_bib68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-12-421","article-title":"Hypoxic enhancement of exosome release by breast cancer cells","volume":"12","author":"King","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2023.01.026_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fonc.2020.00492","article-title":"5-FU-induced up regulation of exosomal PD-L1 causes immune suppression in advanced gastric cancer patients","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1433981","article-title":"PD-1\/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer","volume":"7","author":"Dosset","year":"2018","journal-title":"OncoImmunology"},{"issue":"19","key":"10.1016\/j.gendis.2023.01.026_bib71","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","article-title":"p300\/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6382","key":"10.1016\/j.gendis.2023.01.026_bib73","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.gendis.2023.01.026_bib74","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1002\/jcp.28358","article-title":"PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cei.13113","article-title":"Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients","volume":"192","author":"Theodoraki","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib76","doi-asserted-by":"crossref","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci Adv"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib77","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9\u2013containing exosomes released by Epstein-Barr virus\u2013infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.gendis.2023.01.026_bib78","first-page":"5113","article-title":"T-cell apoptosis and suppression of T-cell receptor\/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors","volume":"9","author":"Taylor","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib79","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","article-title":"Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients","volume":"24","author":"Theodoraki","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib80","doi-asserted-by":"crossref","first-page":"101047","DOI":"10.1016\/j.tranon.2021.101047","article-title":"The role of exosomal PD-L1 in tumor immunotherapy","volume":"14","author":"Wang","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.gendis.2023.01.026_bib81","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1038\/s41467-021-25990-w","article-title":"A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103245","article-title":"Sulfisoxazole elicits robust antitumour immune response along with immune checkpoint therapy by inhibiting exosomal PD-L1","volume":"9","author":"Shin","year":"2022","journal-title":"Adv Sci"},{"issue":"5","key":"10.1016\/j.gendis.2023.01.026_bib83","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.7150\/thno.68864","article-title":"Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1","volume":"12","author":"Lee","year":"2022","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.gendis.2023.01.026_bib84","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrc2171","article-title":"Calcium and cancer: targeting Ca2+ transport","volume":"7","author":"Monteith","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10541-005-0100-9","article-title":"A historical review of cellular calcium handling, with emphasis on mitochondria","volume":"70","author":"Saris","year":"2005","journal-title":"Biochem Mosc"},{"issue":"12","key":"10.1016\/j.gendis.2023.01.026_bib86","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.biochi.2011.07.015","article-title":"Cell proliferation, calcium influx and calcium channels","volume":"93","author":"Capiod","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.gendis.2023.01.026_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.03.002","article-title":"Alterations of calcium homeostasis in cancer cells","volume":"29","author":"Marchi","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.gendis.2023.01.026_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/BSS2007c02","article-title":"The IP3 receptor\/Ca2+ channel and its cellular function","volume":"74","author":"Mikoshiba","year":"2007","journal-title":"Biochem Soc Symp"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib89","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00020.2014","article-title":"Store-operated calcium channels","volume":"95","author":"Prakriya","year":"2015","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib90","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/bph.14632","article-title":"Progress in understanding mitochondrial calcium uniporter complex-mediated calcium signalling: a potential target for cancer treatment","volume":"176","author":"Cui","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2015.01.137","article-title":"Calcium and mitochondria in the regulation of cell death","volume":"460","author":"Orrenius","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/35052055","article-title":"Rab proteins as membrane organizers","volume":"2","author":"Zerial","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41419-021-03825-2","article-title":"Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis","volume":"12","author":"Tan","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib94","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.201109132","article-title":"Munc13-4 reconstitutes calcium-dependent SNARE-mediated membrane fusion","volume":"197","author":"Boswell","year":"2012","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib95","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1091\/mbc.e16-08-0617","article-title":"Munc13-4 functions as a Ca2+ sensor for homotypic secretory granule fusion to generate endosomal exocytic vacuoles","volume":"28","author":"Woo","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.gendis.2023.01.026_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib97","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymthe.2016.10.009","article-title":"Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis","volume":"25","author":"Nishida-Aoki","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.gendis.2023.01.026_bib99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2017.08.020","article-title":"Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras\/Raf\/ERK1\/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells","volume":"408","author":"Datta","year":"2017","journal-title":"Cancer Lett"},{"issue":"19","key":"10.1016\/j.gendis.2023.01.026_bib100","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","article-title":"Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote tumor progression","volume":"72","author":"Bobrie","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2023.01.026_bib101","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","article-title":"High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer","volume":"8","author":"Datta","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2023.01.026_bib102","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41467-019-09387-4","article-title":"Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A","volume":"10","author":"Im","year":"2019","journal-title":"Nat Commun"},{"issue":"50","key":"10.1016\/j.gendis.2023.01.026_bib103","doi-asserted-by":"crossref","first-page":"25965","DOI":"10.1074\/jbc.M116.741884","article-title":"Identification of neutrophil exocytosis inhibitors (nexinhibs), small molecule inhibitors of neutrophil exocytosis and inflammation","volume":"291","author":"Johnson","year":"2016","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.gendis.2023.01.026_bib104","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe-\/- mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.gendis.2023.01.026_bib105","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1038\/ncomms15287","article-title":"Exosomes maintain cellular homeostasis by excreting harmful DNA from cells","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15384047.2017.1394544","article-title":"Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin","volume":"19","author":"Khan","year":"2018","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"10.1016\/j.gendis.2023.01.026_bib107","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.3390\/cells10113247","article-title":"The importance of exosomal PD-L1 in cancer progression and its potential as a therapeutic target","volume":"10","author":"Ye","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gendis.2023.01.026_bib108","doi-asserted-by":"crossref","first-page":"16373","DOI":"10.1038\/s41598-019-52765-7","article-title":"Simvastatin mediates inhibition of exosome synthesis, localization and secretion via multicomponent interventions","volume":"9","author":"Kulshreshtha","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib109","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4062\/biomolther.2014.081","article-title":"Novel suppressive effects of ketotifen on migration and invasion of MDA-MB-231 and HT-1080 cancer cells","volume":"22","author":"Kim","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"10.1016\/j.gendis.2023.01.026_bib110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-9966-29-44","article-title":"Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy","volume":"29","author":"Spugnini","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.gendis.2023.01.026_bib112","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2018.00889","article-title":"Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer","volume":"9","author":"Kosgodage","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.gendis.2023.01.026_bib113","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fcimb.2019.00324","article-title":"Cannabidiol is a novel modulator of bacterial membrane vesicles","volume":"9","author":"Kosgodage","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12039","article-title":"Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo","volume":"10","author":"Leblanc","year":"2020","journal-title":"J Extracell Vesicles"},{"issue":"21","key":"10.1016\/j.gendis.2023.01.026_bib115","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1111\/febs.16133","article-title":"Calcium signaling in cancer progression and therapy","volume":"288","author":"Wu","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.gendis.2023.01.026_bib116","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41467-019-10424-5","article-title":"CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer","volume":"10","author":"Racioppi","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib117","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/emmm.201302989","article-title":"STIM1 and STIM2-mediated Ca2+ influx regulates antitumour immunity by CD8+ T cells","volume":"5","author":"Weidinger","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.gendis.2023.01.026_bib118","doi-asserted-by":"crossref","first-page":"15365","DOI":"10.1038\/ncomms15365","article-title":"Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.gendis.2023.01.026_bib119","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","article-title":"GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner","volume":"68","author":"Jiang","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib120","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.1013285108","article-title":"ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis","volume":"108","author":"Maul-Pavicic","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib121","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/onc.2011.231","article-title":"TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling","volume":"31","author":"Fiorio Pla","year":"2012","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.gendis.2023.01.026_bib122","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1242\/jcs.196659","article-title":"TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells","volume":"130","author":"Azimi","year":"2017","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib123","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.celrep.2015.06.033","article-title":"STIM1 mediates hypoxia-driven hepatocarcinogenesis via interaction with HIF-1","volume":"12","author":"Li","year":"2015","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/path.4413","article-title":"Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2-independent and RACK1-mediated mechanism of HIF-1\u03b1 stabilization","volume":"234","author":"Yu","year":"2014","journal-title":"J Pathol"},{"issue":"17","key":"10.1016\/j.gendis.2023.01.026_bib125","first-page":"3317","article-title":"Crucial role of TRPC6 in maintaining the stability of HIF-1\u03b1 in glioma cells under hypoxia","volume":"128","author":"Li","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.gendis.2023.01.026_bib126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phrs.2014.12.006","article-title":"Enhancement of vascular endothelial growth factor release in long-term drug-treated breast cancer via transient receptor potential channel 5-Ca2+-hypoxia-inducible factor 1\u03b1 pathway","volume":"93","author":"Zhu","year":"2015","journal-title":"Pharmacol Res"},{"issue":"21","key":"10.1016\/j.gendis.2023.01.026_bib127","doi-asserted-by":"crossref","first-page":"11366","DOI":"10.3390\/ijms222111366","article-title":"An emerging role for calcium signaling in cancer-associated fibroblasts","volume":"22","author":"Sadras","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib128","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mc.22642","article-title":"Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF)","volume":"56","author":"Vancauwenberghe","year":"2017","journal-title":"Mol Carcinog"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","article-title":"Calcium signalling in T cells","volume":"19","author":"Trebak","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03526","article-title":"Ca2+ signaling in T lymphocytes: the interplay of the endoplasmic reticulum, mitochondria, membrane potential, and CRAC channels on transcription factor activation","volume":"6","author":"Yang","year":"2020","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.gendis.2023.01.026_bib131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ni713","article-title":"Functional antigen-independent synapses formed between T cells and dendritic cells","volume":"2","author":"Revy","year":"2001","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.smim.2005.02.007","article-title":"Regulation of mature T cell homeostasis","volume":"17","author":"Surh","year":"2005","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib133","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2011.07.011","article-title":"The CaV1.4 calcium channel is a critical regulator of T cell receptor signaling\u00a0and\u00a0naive T cell homeostasis","volume":"35","author":"Omilusik","year":"2011","journal-title":"Immunity"},{"issue":"7430","key":"10.1016\/j.gendis.2023.01.026_bib134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11699","article-title":"Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids","volume":"493","author":"Shi","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2023.01.026_bib135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.gendis.2023.01.026_bib136","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4251\/wjgo.v12.i11.1255","article-title":"Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma","volume":"12","author":"Sheng","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.gendis.2023.01.026_bib137","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13048-021-00830-z","article-title":"CACNA1C is a prognostic predictor for patients with ovarian cancer","volume":"14","author":"Chang","year":"2021","journal-title":"J Ovarian Res"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib138","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Mol Cell"},{"issue":"19","key":"10.1016\/j.gendis.2023.01.026_bib139","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1158\/0008-5472.CAN-19-0086","article-title":"Inactivation of proprotein convertases in T cells inhibits PD-1 expression and creates a favorable immune microenvironment in colorectal cancer","volume":"79","author":"Tom\u00e9","year":"2019","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.gendis.2023.01.026_bib140","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/0008-5472.CAN-17-3297","article-title":"NFATc1 promotes antitumoral effector functions and memory CD8+ T-cell differentiation during non-small cell lung cancer development","volume":"78","author":"Heim","year":"2018","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2023.01.026_bib141","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41419-020-03173-7","article-title":"Quantifying the efficacy of checkpoint inhibitors on CD8+ cytotoxic T cells for immunotherapeutic applications via single-cell interaction","volume":"11","author":"Sullivan","year":"2020","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.gendis.2023.01.026_bib142","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/2326-6066.CIR-19-0608","article-title":"CAMK1D triggers immune resistance of human tumor cells refractory to anti-PD-L1 treatment","volume":"8","author":"Volpin","year":"2020","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.gendis.2023.01.026_bib143","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4049\/jimmunol.2000322","article-title":"TRAF3 acts as a checkpoint of B cell receptor signaling to control antibody class switch recombination and anergy","volume":"205","author":"Chen","year":"2020","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.gendis.2023.01.026_bib144","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/0008-5472.CAN-19-1167","article-title":"Recent advances targeting CCR5 for cancer and its role in immuno-oncology","volume":"79","author":"Jiao","year":"2019","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/exd.14065","article-title":"Blockade of CCR5 in melanoma: an alternative immune checkpoint modulator","volume":"29","author":"Escandon Brehm","year":"2020","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib146","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.gendis.2023.01.026_bib147","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.gendis.2023.01.026_bib148","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gendis.2023.01.026_bib149","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.gendis.2023.01.026_bib150","doi-asserted-by":"crossref","first-page":"108582","DOI":"10.1016\/j.celrep.2020.108582","article-title":"Calcium channel blocker nifedipine suppresses colorectal cancer progression and immune escape by preventing NFAT2 nuclear translocation","volume":"33","author":"Wu","year":"2020","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.gendis.2023.01.026_bib151","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41388-020-01592-6","article-title":"Repurposing screen identifies amlodipine as an inducer of PD-L1 degradation and antitumor immunity","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.gendis.2023.01.026_bib152","doi-asserted-by":"crossref","first-page":"539261","DOI":"10.3389\/fphar.2020.539261","article-title":"Dihydropyridine calcium channel blockers suppress the transcription of PD-L1 by inhibiting the activation of STAT1","volume":"11","author":"Pan","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2023.01.026_bib153","doi-asserted-by":"crossref","first-page":"313","DOI":"10.17480\/psk.2021.65.4.313","article-title":"Characterization of immune checkpoint inhibition efficacy through inhibition of exosome secretion by calcium channel blockers in melanoma","volume":"65","author":"Alam","year":"2021","journal-title":"Yakhak Hoeji"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:38:08Z","timestamp":1762450688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304223000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2352304223000491"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2023.01.026","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The link between intracellular calcium signaling and exosomal PD-L1 in cancer progression and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2023.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}